MicroRNA-29a-3p attenuates ET-1-induced hypertrophic responses in H9c2 cardiomyocytes
- 1 July 2016
- journal article
- Published by Elsevier BV in Gene
- Vol. 585 (1), 44-50
- https://doi.org/10.1016/j.gene.2016.03.015
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31171303, 31070694, 31270837)
- Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (IRT1166)
- Research Fund for the Doctoral Program of Higher Education of China (20111208110001)
This publication has 26 references indexed in Scilit:
- Role of Endothelin in the Induction of Cardiac Hypertrophy In VitroPLOS ONE, 2012
- The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injuryPhysiological Genomics, 2012
- PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4Archives of Biochemistry and Biophysics, 2012
- Adrenergic receptor blockade-induced regression of pressure-overload cardiac hypertrophy is associated with inhibition of the calcineurin/NFAT3/GATA4 pathwayMolecular Medicine Reports, 2010
- Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γ agonist protects against myocardial ischaemia–reperfusion injuryCardiovascular Research, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisProceedings of the National Academy of Sciences of the United States of America, 2008
- MicroRNAs Are Aberrantly Expressed in Hypertrophic Heart: Do They Play a Role in Cardiac Hypertrophy?The American Journal of Pathology, 2007
- Calcium–calcineurin signaling in the regulation of cardiac hypertrophyBiochemical and Biophysical Research Communications, 2004
- Cardiac Hypertrophy: The Good, the Bad, and the UglyAnnual Review of Physiology, 2003